On Monday, the Swiss market spent most of the session in negative territory, only showing some improvement early in the day and just before the close. Nevertheless, the Swiss Market Index (SMI) managed to close slightly higher, buoyed by support for certain leading stocks.
The SMI, having hit a low point of 11,644.53, ultimately recorded a modest increase of 7.08 points or 0.06%, finishing the session at 11,701.51.
Lonza Group saw a notable uplift, rising nearly 2.5%, while Roche Holding appreciated by approximately 1.25%. Other gainers included Partners Group, ABB, Sandoz Group, VAT Group, and Alcon, each advancing between 0.5% and 0.8%.
Biopharmaceutical company Basilea Pharmaceutica surged by 4.6% following its announcement of an exclusive distribution and license agreement with Innoviva Specialty Therapeutics. This partnership is set to commercialize Basilea's hospital-focused anti-MRSA antibiotic, Zevtera (ceftobiprole), in the U.S. market.
In contrast, Swatch Group's shares declined by 2.73%, and Logitech International fell by around 2.1%. Nestle and Lindt & Sprüngli both ended the day with losses of nearly 1%.
Holcim, Sika, Straumann Holding, Swiss Life Holding, Richemont, Swiss Re, SIG Group, Adecco, and UBS Group all experienced declines of between 0.4% and 0.8%.
Regarding economic data, the Federal Statistical Office reported that Switzerland's producer and import prices decreased by 0.6% in November compared to the previous month, marking a third consecutive month of decline following a 0.3% reduction in September. On a yearly basis, these prices fell by 1.5% in November, which was a slight improvement from the 1.8% year-on-year decrease recorded the previous month.
The material has been provided by InstaForex Company -
www.instaforex.com
